Efficacy of androgen deprivation therapy and the role of oxidative stress

被引：6
|
作者：
Price, D. K. [1 ]
机构：
[1] Natl Canc Inst, Natl Inst Hlth, Genitourinary Malignancies Branch, Bethesda, MD USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷 / 03期
基金：
美国国家卫生研究院;
关键词：
RESISTANT PROSTATE-CANCER; INCREASED SURVIVAL; MITOXANTRONE; PREDNISONE;
D O I：
10.1093/annonc/mdx001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：451 / 453
页数：4
相关论文
共 50 条
  • [1] Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2016, 69 (05) : 761 - 763
  • [2] Indications and Complications of Androgen Deprivation Therapy
    Fankhauser, Christian Daniel
    Wettstein, Marian Severin
    Reinhardt, Michele
    Gessendorfer, Axel
    Mostafid, Hugh
    Hermanns, Thomas
    SEMINARS IN ONCOLOGY NURSING, 2020, 36 (04)
  • [3] Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy
    Kadono, Yoshifumi
    Nohara, Takahiro
    Ueno, Satoru
    Izumi, Kouji
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Onozawa, Mizuki
    Hinotsu, Shiro
    Akaza, Hideyuki
    Namiki, Mikio
    WORLD JOURNAL OF UROLOGY, 2016, 34 (02) : 261 - 267
  • [4] miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko, Maria Yu
    Bryzgunova, Olga E.
    Laktionov, Pavel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [5] Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study
    Abedinpour, Parisa
    Baron, Veronique T.
    Chrastina, Adrian
    Rondeau, Gaelle
    Pelayo, Jennifer
    Welsh, John
    Borgstrom, Per
    PROSTATE, 2017, 77 (16) : 1550 - 1562
  • [6] Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
    Min, Kyungchan
    Chung, Jae Wook
    Ha, Yun-Sok
    Lee, Jun Nyung
    Kim, Bum Soo
    Kim, Hyun Tae
    Kim, Tae-Hwan
    Yoo, Eun Sang
    Kwon, Tae Gyun
    Chung, Sung Kwang
    Tanaka, Masatoshi
    Egawa, Shin
    Kimura, Takahiro
    Choi, Seock Hwan
    WORLD JOURNAL OF MENS HEALTH, 2020, 38 (02) : 226 - 235
  • [7] Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
    Fiorica, Francesco
    Buttigliero, Consuelo
    Grigolato, Daniela
    Muraro, Marco
    Turco, Fabio
    Munoz, Fernando
    Tucci, Marcello
    CURRENT ONCOLOGY, 2022, 29 (12) : 9511 - 9524
  • [8] Reconsideration of progression to CRPC during androgen deprivation therapy
    Mizokami, Atsushi
    Namiki, Mikio
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 145 : 164 - 171
  • [9] Rationale for the development of alternative forms of androgen deprivation therapy
    Kumari, Sangeeta
    Senapati, Dhirodatta
    Heemers, Hannelore V.
    ENDOCRINE-RELATED CANCER, 2017, 24 (08) : R275 - R295
  • [10] Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis
    Zhu, Jianhong
    Liao, Rifang
    Su, Chen
    Liang, Dan
    Wu, Junyan
    Qiu, Kaifeng
    Li, Jianfang
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (02) : 193 - 198
12345